Starpharma Holdings Limited

SPHRY · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$10-$8-$16-$16
Dep. & Amort.$1$0$1$1
Deferred Tax$0$0-$6-$5
Stock-Based Comp.$1$0$2$2
Change in WC$2$2-$1-$0
Other Non-Cash-$1-$1$6$4
Operating Cash Flow-$7-$7-$14-$13
Investing Activities
PP&E Inv.-$0-$0-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$1-$1
Financing Activities
Debt Repay.-$1-$4$0$4
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$1-$1-$1
Financing Cash Flow-$1-$5-$1$3
Forex Effect-$0-$0$0$0
Net Chg. in Cash-$8-$12-$15-$11
Supplemental Information
Beg. Cash$23$35$50$61
End Cash$15$23$35$50
Free Cash Flow-$7-$7-$14-$14